Immediate Impact

1 from Science/Nature 64 standout
Sub-graph 1 of 23

Citing Papers

Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis
2025 Standout
Chemically Modified Platforms for Better RNA Therapeutics
2024 Standout
2 intermediate papers

Works of John McKellar being referenced

Assessment of Dose Proportionality: Report from the Statisticians in the Pharmaceutical Industry/Pharmacokinetics UK Joint Working Party
1995

Author Peers

Author Last Decade Papers Cites
John McKellar 770 406 260 349 39 1.8k
Michael J. Bohn 1148 390 168 469 21 2.4k
Roberta Wines 702 339 106 548 27 2.3k
Richard K. Fuller 1368 318 100 257 43 2.5k
Lin Liu 454 341 126 446 95 2.7k
Halle R Amick 957 756 186 211 30 2.7k
David S. Timberlake 514 223 92 389 65 2.3k
Bruce M. Burchett 594 454 234 268 52 2.4k
Xiaowei Yang 487 231 98 375 26 1.6k
Amy Z. Fan 923 395 138 242 41 2.0k
Mark Lemstra 335 594 149 399 58 2.7k

All Works

Loading papers...

Rankless by CCL
2026